156 related articles for article (PubMed ID: 37628931)
1. Sub-Cellular Dynamic Analysis of BGC823 Cells after Treatment with the Multi-Component Drug CKI Using Raman Spectroscopy.
Shang W; Ye A; Tong YK
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628931
[TBL] [Abstract][Full Text] [Related]
2. Raman micro spectroscopy for in vitro drug screening: subcellular localisation and interactions of doxorubicin.
Farhane Z; Bonnier F; Casey A; Byrne HJ
Analyst; 2015 Jun; 140(12):4212-23. PubMed ID: 25919793
[TBL] [Abstract][Full Text] [Related]
3. Cellular discrimination using in vitro Raman micro spectroscopy: the role of the nucleolus.
Farhane Z; Bonnier F; Casey A; Maguire A; O'Neill L; Byrne HJ
Analyst; 2015 Sep; 140(17):5908-19. PubMed ID: 26207998
[TBL] [Abstract][Full Text] [Related]
4. Dynamic characterization of drug resistance and heterogeneity of the gastric cancer cell BGC823 using single-cell Raman spectroscopy.
Zhang Y; Jin L; Xu J; Yu Y; Shen L; Gao J; Ye A
Analyst; 2017 Dec; 143(1):164-174. PubMed ID: 29165440
[TBL] [Abstract][Full Text] [Related]
5. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.
Li L; Wang K; Liu Z; Lü Y; Wang C; Yi X; Guo J
World J Surg Oncol; 2022 May; 20(1):161. PubMed ID: 35590327
[TBL] [Abstract][Full Text] [Related]
6. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
Wu X; Lu Y; Qin X
J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
[TBL] [Abstract][Full Text] [Related]
7. Compound Kushen Injection inhibits epithelial-mesenchymal transition of gastric carcinoma by regulating VCAM1 induced by the TNF signaling pathway.
Huang Z; Wu C; Zhou W; Lu S; Tan Y; Wu Z; You R; Stalin A; Guo F; Zhang J; Liu P; Wang W; Duan X; You L; Wu J
Phytomedicine; 2023 Sep; 118():154984. PubMed ID: 37487253
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
[TBL] [Abstract][Full Text] [Related]
9. An in vitro study of the interaction of the chemotherapeutic drug Actinomycin D with lung cancer cell lines using Raman micro-spectroscopy.
Farhane Z; Bonnier F; Byrne HJ
J Biophotonics; 2018 Jan; 11(1):. PubMed ID: 28703437
[TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer.
Liu X; Bai M; Li H; Ye P; Duan X; Wu C; Huang Z; Lu S; Zhang J; Zhao Z; Guo F; You R; Qin W; Wang W; Han A; Shen L; Wang Y; Zhao Z; Luo H; Wu J
Front Immunol; 2022; 13():965342. PubMed ID: 36389835
[TBL] [Abstract][Full Text] [Related]
11. Monitoring doxorubicin cellular uptake and trafficking using in vitro Raman microspectroscopy: short and long time exposure effects on lung cancer cell lines.
Farhane Z; Bonnier F; Byrne HJ
Anal Bioanal Chem; 2017 Feb; 409(5):1333-1346. PubMed ID: 27888307
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: A systematic review and meta-analysis.
Wang D; Xu Y; Huang T; Peng W; Zhu D; Zhou X; Wu Q
Phytomedicine; 2022 Sep; 104():154315. PubMed ID: 35868145
[TBL] [Abstract][Full Text] [Related]
13. Raman microspectroscopy of nucleus and cytoplasm for human colon cancer diagnosis.
Liu W; Wang H; Du J; Jing C
Biosens Bioelectron; 2017 Nov; 97():70-74. PubMed ID: 28575750
[TBL] [Abstract][Full Text] [Related]
14. Raman spectroscopic analysis of oral cells in the high wavenumber region.
Carvalho LFCS; Bonnier F; Tellez C; Dos Santos L; O'Callaghan K; O'Sullivan J; Soares LES; Flint S; Martin AA; Lyng FM; Byrne HJ
Exp Mol Pathol; 2017 Dec; 103(3):255-262. PubMed ID: 29126766
[TBL] [Abstract][Full Text] [Related]
15. A New Strategy for Identifying Mechanisms of Drug-drug Interaction Using Transcriptome Analysis: Compound Kushen Injection as a Proof of Principle.
Shen H; Qu Z; Harata-Lee Y; Cui J; Aung TN; Wang W; Kortschak RD; Adelson DL
Sci Rep; 2019 Nov; 9(1):15889. PubMed ID: 31685921
[TBL] [Abstract][Full Text] [Related]
16. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway.
Xu W; Lin H; Zhang Y; Chen X; Hua B; Hou W; Qi X; Pei Y; Zhu X; Zhao Z; Yang L
J Exp Clin Cancer Res; 2011 Oct; 30(1):103. PubMed ID: 22032476
[TBL] [Abstract][Full Text] [Related]
17. Comparison of subcellular responses for the evaluation and prediction of the chemotherapeutic response to cisplatin in lung adenocarcinoma using Raman spectroscopy.
Nawaz H; Bonnier F; Meade AD; Lyng FM; Byrne HJ
Analyst; 2011 Jun; 136(12):2450-63. PubMed ID: 21519610
[TBL] [Abstract][Full Text] [Related]
18. Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics.
Qu Z; Cui J; Harata-Lee Y; Aung TN; Feng Q; Raison JM; Kortschak RD; Adelson DL
Oncotarget; 2016 Oct; 7(40):66003-66019. PubMed ID: 27602759
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis.
Shen H; Qu Z; Harata-Lee Y; Aung TN; Cui J; Wang W; Kortschak RD; Adelson DL
Front Oncol; 2019; 9():632. PubMed ID: 31380274
[TBL] [Abstract][Full Text] [Related]
20. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
He R; Ou S; Chen S; Ding S
Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
